Current management of metastatic breast cancer

E. A. Perez

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The medical approach to the management of metastatic breast cancer has changed through the years following the introduction of new cytotoxic agents and the demonstration of their antitumor activity. In general, combination drug regimens are the initial treatments of choice when chemotherapy is indicated for patients with metastatic breast cancer. However, the single- agent activity of some of the newer agents rivals that of older combination chemotherapy treatments. Compared with older therapies, improved objective response rates and/or improved duration of response recently have been reported in studies evaluating optimal dosing and sequencing of these newer agents, alone or in combination with other drugs. Although there is no rigid standard for the sequencing of therapy for management of metastatic breast cancer, chemotherapy has a role in the treatment program for nearly all patients with this disease. The goal of treatment remains meaningful palliation of patients with complications of progressive cancer.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalSeminars in Oncology
Volume26
Issue number4 SUPPL. 12
StatePublished - 1999

Fingerprint

Breast Neoplasms
Therapeutics
Drug Therapy
Cytotoxins
Drug Combinations
Combination Drug Therapy
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Perez, E. A. (1999). Current management of metastatic breast cancer. Seminars in Oncology, 26(4 SUPPL. 12), 1-10.

Current management of metastatic breast cancer. / Perez, E. A.

In: Seminars in Oncology, Vol. 26, No. 4 SUPPL. 12, 1999, p. 1-10.

Research output: Contribution to journalArticle

Perez, EA 1999, 'Current management of metastatic breast cancer', Seminars in Oncology, vol. 26, no. 4 SUPPL. 12, pp. 1-10.
Perez, E. A. / Current management of metastatic breast cancer. In: Seminars in Oncology. 1999 ; Vol. 26, No. 4 SUPPL. 12. pp. 1-10.
@article{9a5d8c35441546228d16c145ede3dde7,
title = "Current management of metastatic breast cancer",
abstract = "The medical approach to the management of metastatic breast cancer has changed through the years following the introduction of new cytotoxic agents and the demonstration of their antitumor activity. In general, combination drug regimens are the initial treatments of choice when chemotherapy is indicated for patients with metastatic breast cancer. However, the single- agent activity of some of the newer agents rivals that of older combination chemotherapy treatments. Compared with older therapies, improved objective response rates and/or improved duration of response recently have been reported in studies evaluating optimal dosing and sequencing of these newer agents, alone or in combination with other drugs. Although there is no rigid standard for the sequencing of therapy for management of metastatic breast cancer, chemotherapy has a role in the treatment program for nearly all patients with this disease. The goal of treatment remains meaningful palliation of patients with complications of progressive cancer.",
author = "Perez, {E. A.}",
year = "1999",
language = "English (US)",
volume = "26",
pages = "1--10",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "4 SUPPL. 12",

}

TY - JOUR

T1 - Current management of metastatic breast cancer

AU - Perez, E. A.

PY - 1999

Y1 - 1999

N2 - The medical approach to the management of metastatic breast cancer has changed through the years following the introduction of new cytotoxic agents and the demonstration of their antitumor activity. In general, combination drug regimens are the initial treatments of choice when chemotherapy is indicated for patients with metastatic breast cancer. However, the single- agent activity of some of the newer agents rivals that of older combination chemotherapy treatments. Compared with older therapies, improved objective response rates and/or improved duration of response recently have been reported in studies evaluating optimal dosing and sequencing of these newer agents, alone or in combination with other drugs. Although there is no rigid standard for the sequencing of therapy for management of metastatic breast cancer, chemotherapy has a role in the treatment program for nearly all patients with this disease. The goal of treatment remains meaningful palliation of patients with complications of progressive cancer.

AB - The medical approach to the management of metastatic breast cancer has changed through the years following the introduction of new cytotoxic agents and the demonstration of their antitumor activity. In general, combination drug regimens are the initial treatments of choice when chemotherapy is indicated for patients with metastatic breast cancer. However, the single- agent activity of some of the newer agents rivals that of older combination chemotherapy treatments. Compared with older therapies, improved objective response rates and/or improved duration of response recently have been reported in studies evaluating optimal dosing and sequencing of these newer agents, alone or in combination with other drugs. Although there is no rigid standard for the sequencing of therapy for management of metastatic breast cancer, chemotherapy has a role in the treatment program for nearly all patients with this disease. The goal of treatment remains meaningful palliation of patients with complications of progressive cancer.

UR - http://www.scopus.com/inward/record.url?scp=0032824734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032824734&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 1

EP - 10

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 4 SUPPL. 12

ER -